�òݸ���

Journal articles

• Zafar H, Passman J, Sandy R, Wright C, Wright F, Evans H, Hanumapura P, Sebastian S, Ebah L, Khalifa A , Rowe S et al (2024) . European Heart Journal, 45(Supplement_1).
• Evans H, Andrews R, Abedi FA, Sprules A, Trend J, Lovric G, Green A, Chantry A, Clarkin C, Brown J & Lawson M (2024) . JBMR Plus, 8(9).
• Diaz-delCastillo M, Palasca O, Nemler TT, Thygesen DM, Chávez-Saldaña NA, Vázquez-Mora JA, Ponce Gomez LY, Jensen LJ, Evans H, Andrews RE , Mandal A et al (2023) . The Journal of Neuroscience, 43(29), 5414-5430.
• Cox TR, Rumney RMH, Schoof EM, Perryman L, Høye AM, Agrawal A, Bird D, Latif NA, Forrest H, Evans HR , Huggins ID et al (2023) . Nature, 617(7959), 208-208.
• Fan R, Satilmis H, Vandewalle N, Verheye E, Vlummens P, Maes A, Muylaert C, De Bruyne E, Menu E, Evans H , Chantry A et al (2023) . Journal for ImmunoTherapy of Cancer, 11(1).
• Diaz-delCastillo M, Nemler T, Thygesen DM, Chávez-Saldaña NA, Vázquez-Mora JA, Palasca O, Juhl L, Evans H, Andrews RE, Mandal A , Chantry AD et al (2022) . Clinical Lymphoma Myeloma and Leukemia, 22, S108-S108.
• Fan R, Satilmis H, Vandewalle N, De Bruyne E, Menu E, Chantry AD, Evans H, Törngren M, Eriksson H, Breckpot K , Maes K et al (2021) . Blood, 138(Supplement 1), 1594-1594.
• Zhang D, De Veirman K, Fan R, Jian Q, Zhang Y, Lei L, Evans H, Wang Y, Lei L, Wang B , Williamson RA et al (2020) . Stem Cell Research & Therapy, 11(1).
• Green AC, Lath D, Hudson K, Walkley B, Down JM, Owen R, Evans HR, Paton‐Hough J, Reilly GC, Lawson MA & Chantry AD (2019) . Journal of Bone and Mineral Research, 34(12), 2311-2326.
• Barker HE, Chang J, Cox TR, Lang G, Bird D, Nicolau M, Evans HR, Gartland A & Erler JT (2019) . Cancer Research, 79(19), 5123-5123.
• Leitch VD, Brassill MJ, Rahman S, Butterfield NC, Ma P, Logan JG, Boyde A, Evans H, Croucher PI, Batterham RL , Williams GR et al (2019) . Bone, 127, 427-435.
• Paton-Hough J, Tazzyman S, Evans H, Lath D, Down JM, Green AC, Snowden JA, Chantry AD & Lawson MA (2019) . Journal of Bone and Mineral Research, 34(5), 783-796.
• Lath DL, Buckle CH, Evans HR, Fisher M, Down JM, Lawson MA & Chantry AD (2018) . PLoS One, 13(6).
• Lawson MA, Ebetino FH, Mazur A, Chantry AD, Paton-Hough J, Evans HR, Lath D, Tsoumpra MK, Lundy MW, Dobson RLM , Quijano M et al (2017) . Journal of Bone and Mineral Research, 32(9), 1860-1869.
• Leitch VD, Di Cosmo C, Liao X-H, O'Boy S, Galliford TM, Evans H, Croucher PI, Boyde A, Dumitrescu A, Weiss RE , Refetoff S et al (2017) . Endocrinology, 158(9), 3055-3066.
• Evans HR, Karmakharm T, Lawson MA, Walker RE, Harris W, Fellows C, Huggins ID, Richmond P & Chantry AD (2016) . Bone, 83, 9-16.
• Kassen D, Lath D, Lach A, Evans H, Chantry A, Rabin N, Croucher P & Yong KL (2016) . British Journal of Haematology, 172(1), 64-79.
• Cox TR, Rumney RMH, Schoof EM, Perryman L, Høye AM, Agrawal A, Bird D, Ab Latif N, Forrest H, Evans HR , Huggins ID et al (2015) . NATURE, 522(7554), 106-110.
• Lawson MA, Paton-Hough JM, Evans HR, Walker RE, Harris W, Ratnabalan D, Snowden JA & Chantry AD (2015) . PLOS ONE, 10(3).
• Bassett JHD, Boyde A, Zikmund T, Evans H, Croucher PI, Zhu X, Park JW, Cheng S-Y & Williams GR (2014) . Endocrinology, 155(9), 3699-3712.
• Bentley L, Esapa CT, Nesbit MA, Head RA, Evans H, Lath D, Scudamore CL, Hough TA, Podrini C, Hannan FM , Fraser WD et al (2014) . Endocrinology, 155(3), 908-922.
• Xu S, De Veirman K, Evans H, Santini GC, Vande Broek I, Leleu X, De Becker A, Van Camp B, Croucher P, Vanderkerken K & Van Riet I (2013) . Acta Pharmacologica Sinica, 34(5), 699-709.
• Loh NY, Bentley L, Dimke H, Verkaart S, Tammaro P, Gorvin CM, Stechman MJ, Ahmad BN, Hannan FM, Piret SE , Evans H et al (2013) . PLoS One, 8(1), e55412.
• Esapa CT, Bassett JHD, Evans H, Croucher PI, Williams GR & Thakker RV (2012) . Current Protocols in Mouse Biology, 2(4), 365-400.
• Chantry AD, Heath D, Mulivor AW, Pearsall S, Baud'huin M, Coulton L, Evans H, Abdul N, Werner ED, Bouxsein ML , Key ML et al (2012) . Journal of Bone and Mineral Research, 27(9), 2036-2037.
• Esapa CT, Head RA, Jeyabalan J, Evans H, Hough TA, Cheeseman MT, McNally EG, Carr AJ, Thomas GP, Brown MA , Croucher PI et al (2012) . Plos One, 7(8).
• Bassett JHD, Gogakos A, White JK, Evans H, Jacques RM, van der Spek AH, Sanger Mouse Genetics Project , Ramirez-Solis R, Ryder E, Sunter D , Boyde A et al (2012) . PLoS Genet, 8(8), e1002858.
• Bassett JHD, Logan JG, Boyde A, Cheung MS, Evans H, Croucher P, Sun X-Y, Xu S, Murata Y & Williams GR (2012) . Endocrinology, 153(7), 3537-3548.
• Xu S, De Becker A, De Veirman K, Hu J, Xu D, Menu E, Vande Broek I, Camp BV, Vanderkerken K, Van Riet I , Evans H et al (2012) . Leukemia.
• Barker HE, Chang J, Cox TR, Lang G, Bird D, Nicolau M, Evans HR, Gartland A & Erler JT (2011) . Cancer Res, 71(5), 1561-1572.
• Chantry AD, Heath D, Mulivor AW, Pearsall S, Baud'huin M, Coulton L, Evans H, Abdul N, Werner ED, Bouxsein ML , Key ML et al (2010) . J Bone Miner Res, 25(12), 2633-2646.
• Bassett JHD, Boyde A, Howell PGT, Bassett RH, Galliford TM, Archanco M, Evans H, Lawson MA, Croucher P, Germain DLS , Galton VA et al (2010) . P NATL ACAD SCI USA, 107(16), 7604-7609.
• Heath DJ, Chantry AD, Buckle CH, Coulton L, Shaughnessy JD, Evans HR, Snowden JA, Stover DR, Vanderkerken K & Croucher PI (2009) . J Bone Miner Res, 24(3), 425-436.
• Heath DJ, Chantry AD, Buckle C, Coulton L, Shaughnessy JD, Evans H, Stover DR, Vanderkerken K & Croucher PI (2008) Inhibiting Dickkopf-1 (Dkk-1) prevents the development of osteolytic bone disease in multiple myeloma. CALCIFIED TISSUE INT, 83(1), 6-6.
• Chantry A, Heath D, Coulton L, Gallagher O, Evans H, Vanderkerken K, Seehra JS & Croucher PI (2008) RAP-011, a soluble activin receptor type IIA IgG-Fc fusion protein, is a novel bone anabolic agent that prevents bone disease in multiple myeloma. CLIN EXP METASTAS, 25, 64-64.
• Kirby J, Hewamadduma CAA, Hartley JA, Nixon HC, Evans H, Wadhwa RR, Kershaw C, Ince PG & Shaw PJ (2007) . Neurology, 68(22), 1951-1953.
• Leitch VD, Di CC, Liao X-H, O'Boy S, Galliford TM, Evans H, Croucher PI, Boyde A, Dumitrescu A, Weiss RE , Refetoff S et al () . Endocrine Abstracts.
• Lawson M, Chantry A, Paton-Hough J, Evans H, Lath D, Tsoumpra M, Lundy M, Dobson R, Quijano M, Kwaasi A , Dunford J et al () . Bone Abstracts.
• Bassett JHD, Boyde A, Zikmund T, Evans H, Croucher PI, Zhu X, Park JW, Cheng S-Y & Williams GR () . Endocrine Abstracts.
• Bentley L, Esapa CT, Nesbit MA, Head RA, Evans H, Lath D, Hough TA, Podrini C, Fraser WD, Croucher PI , Brown MA et al () . Endocrine Abstracts, 1-1.
• Esapa C, Hough T, Evans HR, Testori S, Head R, Crane E, Chan C, Bassett J, Tylzanowski P & McNally E () A mouse model for spondyloepiphyseal dysplasia congenita with secondary osteoarthritis due to a Col2a1 mutation. J Bone Miner Res..

Conference proceedings

• Zafar H, Passman J, Sandy R, Wright C, Wright F, Evans H, Ebah L, Ilyas D, Hanumapura P, Sebastien S , Khalifa A et al (2023) . Basic Science (pp A298.2-A300)
• Diaz-DelCastillo M, Nemler T, Thygesen DM, Chavez-Saldana NA, Vazquez-Mora JA, Palasca O, Juhl L, Evans H, Andrews RE, Mandal A , Chantry AD et al (2023) Mechanisms of Bone Pain in Multiple Myeloma: Involvement of Periosteal Bone Sprouting. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 55-56)
• Diaz-delCastillo M, Nemler T, Thygesen DM, Chavez-Saldana NA, Vazquez-Mora JA, Palasca O, Juhl L, Evans H, Andrews RE, Mandal A , Chantry AD et al (2022) Myeloma-induced bone pain: lessons learnt from a localized, immunocompetent mouse model. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, Vol. 22 (pp S108-S108)
• Zhu Y, Green AC, Guo L, Evans HR & Mihaylova L (2020) . Proceedings of 2020 IEEE 23rd International Conference on Information Fusion (FUSION) (pp 1-6). Rustenburg, South Africa, 6 July 2020 - 6 July 2020.
• Zhu Y, Green AC, Guo L, Evans HR & Mihaylova L (2020) Machine Learning Approaches for Cancer Bone Segmentation from Micro Computed Tomography Images. PROCEEDINGS OF 2020 23RD INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION 2020) (pp 1263-1268)
• Arnold ND, Pickworth JA, Carvalho JA, Braithwaite AT, Iremonger J, West L, Casbolt HL, Renshall LJ, Germaschewski V, McCourt M , Evans HR et al (2017) Development of a Novel Human Anti-OPG Antibody That Attenuates Experimental Pulmonary Arterial Hypertension. CIRCULATION, Vol. 136
• Chantry AD, Baud'huin M, Coulton L, Gallagher O, Evans H, Lath D, Seehra J, Pearsall S, De Raeve H, Vanderkerken K & Croucher PI (2011) Blockade of the ALK1 receptor reduces tumour microvessel density and prevents the development of osteolytic bone disease in the 5T2MM murine model of myeloma. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 153 (pp 7-7)
• Evans HR, Ab Latif N, Cox TR, Bird D, Lang G, Erler JT & Gartland A (2011) . BONE, Vol. 48(1) (pp S21-S21)
• Williams A, Lawson M, Bos T, Amani E, Hough J, Evans H, Lath D, Gallagher O, Coulton L, Vanderkerken K & Croucher P (2010) . BONE, Vol. 47 (pp S328-S328)
• Abdul N, Stoop W, Koopman W, Djerbi M, Chantry AD, Evans H, Vanderkerken K & Croucher PI (2009) . BONE, Vol. 44 (pp S53-S54)
• Chantry A, Coulton L, Gallagher O, Evans H, Seehra J, Pearsall S, De Raeve H, Vanderkerken K & Croucher R (2009) . BONE, Vol. 44 (pp S55-S55)
• Orriss IR, Evans HR, Gartland A & Arnett TR (2008) Microct analysis of P2Y1 and P2Y2 receptor knockout mice demonstrates significant changes in bone phenotype. CALCIFIED TISSUE INT, Vol. 83(1) (pp 2-3)
• Orriss I, Evans H, Arnett T & Gartland A (2008) MicroCT analysis of P2Y1 and P2Y2 receptor knockout mice demonstrates significant changes in bone phenotype. PURINERG SIGNAL, Vol. 4 (pp S176-S176)
• Chantry A, Heath D, Coutton L, Evans H, Abdul N, Seehra J, Vanderkerken K & Croucher P (2008) . CANCER TREATMENT REVIEWS, Vol. 34 (pp S56-S57)
• Heath D, Chantry A, Buckle C, Coulton L, Shaughnessy J, Evans H, Stover D, Vanderkerken K & Croucher P (2008) . CANCER TREATMENT REVIEWS, Vol. 34 (pp S52-S52)
• Chantry AD, Heath D, Coulton L, Gallagher O, Evans H, Seehra J, Vanderkerken K & Croucher PI (2007) A soluble activin type II receptor prevents myeloma bone disease. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 22(7) (pp 1118-1118)
• Chantry A, Heath D, Coulton L, Gallagher O, Evans H, Seehra J, Vanderkerken K & Croucher PI (2007) A soluble activin type II receptor prevents myeloma bone disease. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, Vol. 92(6) (pp 133-133)

Preprints

• Diaz-delCastillo M, Palasca O, Nemler TT, Thygesen DM, Chávez-Saldaña NA, Vázquez-Mora JA, Ponce Gomez LY, Jensen LJ, Evans H, Andrews RE , Mandal A et al (2022) , Cold Spring Harbor Laboratory.